Harnessing Disruption to Accelerate Innovation in Cancer Care (Presented by MSK Direct) - On Demand

Monday, May 17, 2021, 11:00 AM - Tuesday, May 31, 2022, 12:00 PM

This complimentary series entitled Harnessing Disruption to Accelerate Innovation in Cancer Care is sponsored by MSK Direct and includes four lectures focused on the innovative clinical care available at MSK.

• Dr. Bob T. Li and Dr. Oren Cahlon speak on innovation in cancer care and delivery methods that will improve access to quality cancer care (recorded May 13, 2021).
• Dr. Carol Brown discusses disparities that exist for cancer and the work MSK is doing to reduce those disparities (recorded May 20, 2021).
• Dr. Peter Bach provides an overview of the drug pricing landscape and some potential solutions to curb unsustainable costs. (recorded May 27, 2021).

These recordings are accessible to all on a complimentary basis. To access videos, select the 'Course Content' tab above. CME credit is available for these recordings. Instructions for completing an evaluation and claiming credit can also be found under the content tab.

The MSK Direct Program works with benefits leaders/medical directors at employer/union organizations to offer a national comprehensive employee benefits program that reduces the total burden of cancer for companies and their employees. For more information on the MSK Direct program, visit mskcc.org/mskdirect.

1. Apply learnings to employee or member benefits design
2. Describe strategies that employers or unions have used to facilitate access to high-quality cancer care
3. Identify disparities that exist in cancer health
4. Describe issues that exist within the pharmaceutical drug pricing landscape

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: May 13,20 and 27, 2020; Original Release Date: May 20, 2021; Termination Date: May 31, 2022

MSK Speakers

Peter B. Bach, MD, MAPP
Director, Center for Health Policy and Outcomes

Carol L. Brown, MD, FACOG, FACS
Senior Vice President and Chief Health Equity Officer

Oren Cahlon, MD
Deputy Physician-in-Chief for Strategic Partnerships
Vice Chair, Department of Radiation Oncology

Bob T. Li, MD, PhD, MPH
Physician Ambassador to China and Asia-Pacific, Bobst International Center
Co-Director, Thoracic Liquid Biopsy Program
Chief Scientific Officer, MSK Direct

Faculty Disclosures